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AnattenuatedBacillus anthracisvaccine strain forhumanuse,A16R,wasobtained inChinaafterultraviolet
radiation treatment and continuous subculture of the wild-type strain A16. A16R can synthesize the
exotoxin, but without a capsule. We sequenced and annotated the A16R genome to encourage the use of
this strain. The genome sequencing of thewild-type strain A16 is underway and the genomic comparison
between the two strains will help to illustrate the attenuating mechanism of the A16R vaccine strain.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Bacillus anthracis, a Gram-positive, non-motile, spore-forming
bacillus, is the etiological agent of anthrax. Although anthrax is pri-
marily a disease of herbivores, B. anthracis is a highly pathogenic
bacterium that can infect all mammals, including humans (Bell,
1880; Brachman, 1970; Hambleton et al., 1984). The major viru-
lence factors of B. anthracis are encoded on two virulence plasmids
pXO1 and pXO2. Plasmid pXO1 (181.6 kb) encodes the anthrax
toxin proteins, termed protective antigen, lethal factor and edema
factor (Leppla, 1982, 1984; Mikesell et al., 1983). Plasmid pXO2
(96.2 kb) contains the genes capA/B/C, required for capsule biosyn-
thesis and the dep gene, which is involved in the depolymerization
of the capsule (Drysdale et al., 2005; Green et al., 1985). Both plas-
mids are necessary for full virulence, and loss of either of them
will result in an attenuated strain (Mock and Fouet, 2001). Atten-
uated B. anthracis strain A16R (available from the China Medical
Culture Collection, CMCC 63,001), which was obtained in China
after performing ultraviolet radiation and continuous subculture of
thewild-type strainA16, isusedasahumanvaccineagainst anthrax
in China. A16R can synthesize the exotoxin, but without a capsule.
We sequenced and annotated the A16R genome to encourage the
use of this strain.
Whole-genome sequencing of A16R was performed using
Solexa sequencing technology at the Beijing Genomics Institute
(BGI, Shenzhen, China). Genomic libraries containing 0.5-kb inserts
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Table 1
Features of the genome of Bacillus anthracis strain A16R.
Feature Chromosome pXO1
Size [bp] 5,227,683 181,763
GC content [%] 35.4 32.5
Total number of genes 5,593 171
Protein coding genes (CDSs) 5,115 161
Pseudogenes 351 10
rRNAs 33 0
tRNAs 93 0
ncRNA 1 0
were constructed. A total of 500 million high-quality base pairs,
giving 95.6-fold coverage of the genome, were assembled into 65
contigs using by SOAP denovo software (http://soap.genomics.org.
cn). Then, the contigs were joined into 44 scaffolds using paired-
end information. Contigs gaps were ﬁlled through sequencing of
PCR products. Prediction of putative open reading frames was per-
formedusingGlimmer3 (version3.02) (http://www.cbcb.umd.edu/
software/glimmer/), and gene functionswere annotated by search-
ing in the Clusters of Orthologous Genes database with BLASTp
(e-value <1e-10, identity >80%). All genes were further categorized
according to SwissProt, GO (GeneOntology) andKEGG (KyotoEncy-
clopedia of Genes and Genomes).
The genome of B. anthracis vaccine strain A16R comprises a
circular chromosome and a mega-plasmid. The chromosome is
5227,683bp, with a G+C content of 35.4%, and the large plas-
mid pXO1 contains 181,763bp, with a G+C content of 32.5%.
The chromosome of A16R contains 5593 predicted genes (5115
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CDSs, 127 RNAs and 351 pseudogenes). The virulence plasmid
pXO1 contained 161 coding sequences (CDSs) and 10 pseudogenes.
Ninety-three tRNAgenes for all 20 aminoacids andeleven16S-23S-
5S rRNAoperonswere identiﬁed (Table 1). All RNAswere identiﬁed
in the chromosome.
Nucleotide sequence accession numbers
Genome information for the chromosome and plasmid of B.
anthracis vaccine strain A16R were deposited in GenBank under
the accession numbers CP001974 and CP001975, respectively.
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